RGD Reference Report - CTNS mutations in an American-based population of cystinosis patients. - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CTNS mutations in an American-based population of cystinosis patients.

Authors: Shotelersuk, V  Larson, D  Anikster, Y  McDowell, G  Lemons, R  Bernardini, I  Guo, J  Thoene, J  Gahl, WA 
Citation: Shotelersuk V, etal., Am J Hum Genet. 1998 Nov;63(5):1352-62.
RGD ID: 11064664
Pubmed: PMID:9792862   (View Abstract at PubMed)
PMCID: PMC1377545   (View Article at PubMed Central)
DOI: DOI:10.1086/302118   (Journal Full-text)

Nephropathic cystinosis is an autosomal recessive lysosomal storage disease characterized by renal failure at 10 years of age and other systemic complications. The gene for cystinosis, CTNS, has 12 exons. Its 2.6-kb mRNA codes for a 367-amino-acid putative cystine transporter with seven transmembrane domains. Previously reported mutations include a 65-kb "European" deletion involving marker D17S829 and 11 small mutations. Mutation analysis of 108 American-based nephropathic cystinosis patients revealed that 48 patients (44%) were homozygous for the 65-kb deletion, 2 had a smaller major deletion, 11 were homozygous and 3 were heterozygous for 753G-->A (W138X), and 24 had 21 other mutations. In 20 patients (19%), no mutations were found. Of 82 alleles bearing the 65-kb deletion, 38 derived from Germany, 28 from the British Isles, and 4 from Iceland. Eighteen new mutations were identified, including the first reported missense mutations, two in-frame deletions, and mutations in patients of African American, Mexican, and Indian ancestry. CTNS mutations are spread throughout the leader sequence, transmembrane, and nontransmembrane regions. According to a cystinosis clinical severity score, homozygotes for the 65-kb deletion and for W138X have average disease, whereas mutations involving the first amino acids prior to transmembrane domains are associated with mild disease. By northern blot analysis, CTNS was not expressed in patients homozygous for the 65-kb deletion but was expressed in all 15 other patients tested. These data demonstrate the origins of CTNS mutations in America and provide a basis for possible molecular diagnosis in this population.

RGD Manual Disease Annotations    Click to see Annotation Detail View
TermQualifierEvidenceWithReferenceNotesSourceOriginal Reference(s)
cystinosis  IAGP 11064664DNA:mutations:multiple (human)RGD 
cystinosis  ISOCTNS (Homo sapiens)11064664; 11064664DNA:mutations:multiple (human)RGD 

Phenotype Annotations    Click to see Annotation Detail View

Manual Human Phenotype Annotations - RGD

TermQualifierEvidenceWithReferenceNotesSourceOriginal Reference(s)
Abnormal renal physiology  IAGP 11064664DNA:mutations:multiple RGD 
Elevated intracellular cystine  IAGP 11064664DNA:mutations:multiple RGD 
Objects Annotated

Genes (Rattus norvegicus)
Ctns  (cystinosin, lysosomal cystine transporter)

Genes (Mus musculus)
Ctns  (cystinosis, nephropathic)

Genes (Homo sapiens)
CTNS  (cystinosin, lysosomal cystine transporter)


Additional Information